4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-015423
President and COO sold 17,392 shares at $18.16 ($315,893)
- President and COO acquired 12,892 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2026-03-03 | Option exercise 10b5-1 | +12,892 | $3.79 | $48,858 | 222,533 | D |
| Cohlhepp Ryan President and COO | 2026-03-03 | Sale 10b5-1 | −12,892 | $18.16 | $234,159 | 209,641 | D |
| Cohlhepp Ryan President and COO | 2026-03-03 | Sale 10b5-1 | −4,500 | $18.16 | $81,734 | 205,141 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President and COO | 2026-03-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,892 | 125,334 | D | ||
| Open-market sales · 17,392 sh · avg $18.16 · $315,893 | |||||||
Loading xslF345X05/wk-form4_1772755827.xml…